<VariationArchive VariationID="11447" VariationName="NC_000023.11:g.(154556377_154558531)_(154565046_?)del" VariationType="Deletion" Accession="VCV000011447" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26486" VariationID="11447">
      <GeneList>
        <Gene Symbol="IKBKG" FullName="inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" GeneID="8517" HGNC_ID="HGNC:5961" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154541238" stop="154565046" display_start="154541238" display_stop="154565046" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153770458" stop="153793260" display_start="153770458" display_stop="153793260" Strand="+" />
          </Location>
          <OMIM>300248</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IKBKG">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC107988021" FullName="IKBKG recombination region" GeneID="107988021" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154556498" stop="154558301" display_start="154556498" display_stop="154558301" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(154556377_154558531)_(154565046_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" outerStart="154556377" innerStart="154558531" innerStop="154565046" display_start="154556377" display_stop="154565046" variantLength="8670" />
      </Location>
      <OtherNameList>
        <Name>NEMOdelta4_10</Name>
        <Name>EXON 4-10 DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(154556377_154558531)_(154565046_?)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(154556377_154558531)_(154565046_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="IKBKG_000004" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="300248.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 300248.0001 from the record in https://lovd.nl/IKBKG.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(154556377_154558531)_(154565046_?)del AND Incontinentia pigmenti syndrome" Accession="RCV000012200" Version="18">
        <ClassifiedConditionList TraitSetID="3124">
          <ClassifiedCondition DB="MedGen" ID="C0021171">Incontinentia pigmenti syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-09-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-09-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-09-19" MostRecentSubmission="2024-07-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10839543</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11590134</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3124" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2304" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti, familial male-lethal type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bloch-Sulzberger syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Incontinentia pigmenti type 2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IP2 (formerly)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Incontinentia pigmenti syndrome</ElementValue>
                <XRef ID="Incontinentia+pigmenti/3798" DB="Genetic Alliance" />
                <XRef ID="367520004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCONTINENTIA PIGMENTI, TYPE II</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IP</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IP2</ElementValue>
                <XRef Type="MIM" ID="308300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6778" />
                <XRef ID="6778" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Incontinentia pigmenti (IP) is a disorder that affects the skin, hair, teeth, nails, eyes, and central nervous system; it occurs primarily in females and on occasion in males. Characteristic skin lesions evolve through four stages: I. Blistering (birth to age ~4 months). II. Wart-like rash (for several months). III. Swirling macular hyperpigmentation (age ~6 months into adulthood). IV. Linear hypopigmentation. Alopecia, hypodontia, abnormal tooth shape, and dystrophic nails are observed. Neovascularization of the retina, present in some individuals, predisposes to retinal detachment. Neurologic findings including seizures, intellectual disability, and developmental delays are occasionally seen.</Attribute>
                <XRef ID="NBK1472" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301645</ID>
                <ID Source="BookShelf">NBK1472</ID>
              </Citation>
              <XRef ID="464" DB="Orphanet" />
              <XRef ID="C0021171" DB="MedGen" />
              <XRef ID="MONDO:0010631" DB="MONDO" />
              <XRef Type="MIM" ID="308300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32434" SubmissionDate="2020-06-10" DateLastUpdated="2024-07-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300248.0001_INCONTINENTIA PIGMENTI" title="IKBKG, EX4-10DEL_INCONTINENTIA PIGMENTI" />
        <ClinVarAccession Accession="SCV000032434" DateUpdated="2024-07-29" DateCreated="2013-04-04" Type="SCV" Version="7" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-09-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In male and female fetuses with incontinentia pigmenti (IP; 308300), The International Incontinentia Pigmenti Consortium (2000) found a genomic rearrangement resulting in deletion of part of the NEMO gene. An 870-bp region of identity corresponding to an MER67B repeat exists in the NEMO gene both in intron 3 and 3-prime to exon 10; recombinations between the regions of identity delete exons 4 though 10 of NEMO. The International Incontinentia Pigmenti Consortium (2000) stated that this rearrangement accounts for 80% of new IP mutations. This rearrangement would result in a truncated molecule carrying the 133 N-terminal amino acids of NEMO plus at least 26 novel amino acids. It was predicted that this molecule would contain part of the first coiled-coil domain, and may still interact with IKK2 (603258), but would be unlikely to respond to upstream signals. Failure of I-kappa-B-alpha (164008) degradation and lack of NF-kappa-B (see 164011) activation were demonstrated in IP embryonic fibroblasts.</Attribute>
              <Citation>
                <ID Source="PubMed">10839543</ID>
              </Citation>
              <XRef DB="OMIM" ID="308300" Type="MIM" />
              <XRef DB="OMIM" ID="603258" Type="MIM" />
              <XRef DB="OMIM" ID="164008" Type="MIM" />
              <XRef DB="OMIM" ID="164011" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Aradhya et al. (2001) identified 277 mutations in 357 unrelated IP patients. The recurrent deletion of exons 4 to 10 accounted for 90% of the identified mutations. The remaining mutations were small duplications, substitutions, and deletions.</Attribute>
              <Citation>
                <ID Source="PubMed">11590134</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IKBKG" />
          </GeneList>
          <Name>IKBKG, EX4-10DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX4-10DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300248.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INCONTINENTIA PIGMENTI</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32434" TraitType="Disease" MappingType="Name" MappingValue="INCONTINENTIA PIGMENTI" MappingRef="Preferred">
        <MedGen CUI="C0021171" Name="Incontinentia pigmenti syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

